Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
>>
Phase 1
1
2
3
4
5
6
7
8
9
10
11
12
13
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
CP-870893
/ Pfizer
CD19/BCMA chimeric antigen receptor T cells
/ Zhejiang University
SENL101
/ SenlangBio
CD19/BCMA targeted CAR T-cells
/ Shanghai Yake Biotech
CTA101
/ Nanjing Bioheng Biotech
RD13-02
/ Nanjing Bioheng Biotech
ASP2408
/ Astellas
FT538
/ Fate Therap
KN5501
/ Nanjing Enricnk Biotech
Meta10-19
/ Leman Biotech
SNC103
/ Shanghai Simnova Bio
TQB2928
/ Sino Biopharm
anti-CD19/CD22 CAR-T cells
/ Hrain Biotech
lodapolimab
(LY3300054) / Eli Lilly
voruciclib
(ME-522) / MEI
BRL-301
/ BRL Medicine
FT516
/ Fate Therap
NG-350A
/ Akamis Bio
RPM CD19-mbIL15-CAR-T cells
/ Alaunos Therap, UT MD Anderson Cancer Center, Eden BioCell
SL-172154
/ Shattuck
Senl_22
/ SenlangBio
Senl_H19x22P
/ SenlangBio
Sym021
/ Servier, Takeda
TI-1007
/ Timmune Biotech, Shenzhen Beike Biotech
YTS101
/ BriSTAR Immunotech
YTS104
/ BriSTAR Immunotech, Beijing Qingyi Taike Pharma
dalnicastobart
(LVGN7409) / Lyvgen
rHSV-1-APD1
/ Yangshengtang
ACTR087
/ Cogent Biosci
ADI-001
/ Adicet Bio
AGT103-T
/ American Gene Technologies
BMS-986326
/ BMS
BMS-986353
/ BMS
CB CAR-NK019
/ Zhejiang University
CD123 CAR T-cell therapy
/ Tianjin First Central Hospital
CD19 specific CAR T cell therapy
/ Baylor Scott & White Research Institute
CD19-7×19 CAR-T
/ Zhejiang University
CD19.t-haNK
/ ImmunityBio
CT-RD06
/ Nanjing Bioheng Biotech
CTD401
/ Nanjing Bioheng Biotech
ERY974
/ Roche
ET-190
/ Eureka Therap
FT596
/ Fate Therap
GC019F
/ AstraZeneca
GZ402668
/ Sanofi
HLX35
/ Binacea Pharma
Hu-Mik-Beta-1
/ National Institute of Neurological Disorders and Stroke
IBI321
/ Innovent Biologics, Eli Lilly
ICG122
/ iCell Gene Therap
INCB99318
/ Incyte
1
2
3
4
5
6
7
8
9
10
11
12
13
»
